If you live north of about 37° latitude and you haven't been supplementing, your vitamin D may be at its annual low right now. The UV-B rays responsible for skin synthesis can't reach the earth's surface at meaningful intensity above roughly 37° north latitude between November and March. That covers most of the continental US - for nearly half the year.
This isn't a fringe finding. The third National Health and Nutrition Examination Survey (NHANES III) found that approximately 35% of US adults have 25-hydroxyvitamin D below 20 ng/mL - the threshold most guidelines may define as deficient. In late winter, that proportion can climb higher. Among women with darker skin pigmentation (which can require longer UV exposure for equivalent synthesis), rates of deficiency can be substantially higher year-round.
What vitamin D actually does
Vitamin D is technically a hormone precursor, not a vitamin. Its active form - 1,25-dihydroxyvitamin D - binds to receptors in virtually every tissue in the body. The functions most people know about are skeletal: calcium absorption, bone mineralisation, fracture risk reduction. But the receptor distribution tells a wider story.
- Bone density - the most established function; deficiency can accelerate perimenopausal bone loss.
- Immune regulation - vitamin D can modulate both innate and adaptive immunity; deficiency can be associated with higher autoimmune disease incidence.
- Insulin sensitivity - receptor expression in pancreatic beta cells; low D can be associated with higher type 2 diabetes risk (Song et al., 2013).
- Mood - seasonal affective disorder can strongly correlate with latitude and winter vitamin D nadir.
- Muscle function - fast-twitch fibre recruitment can require adequate D; low levels can increase fall risk independently of bone density.
The sufficiency debate
The IOM (Institute of Medicine) set its sufficiency threshold at 20 ng/mL based primarily on bone health endpoints (Ross et al., 2011). The Endocrine Society's 2011 Clinical Practice Guideline recommends 30 ng/mL as the minimum for overall health - and notes that optimal for bone and muscle function may require 40–60 ng/mL, particularly in perimenopausal and postmenopausal women.
Test 25(OH)D, not 1,25(OH)2D
The active form of vitamin D - 1,25-dihydroxyvitamin D - is tightly regulated by the kidney and can be normal or even elevated in vitamin D deficiency (Holick, 2009). Testing it instead of 25(OH)D can give false reassurance. Always test 25-hydroxyvitamin D (calcidiol) for status assessment (Holick et al., 2011).
Women-specific considerations
Perimenopause and bone loss
Bone density loss can accelerate sharply in the two to three years around the final menstrual period - some women may lose 2–3% of bone mass per year during this window (Greendale et al., 2012). Adequate vitamin D (alongside calcium and resistance training) can be the foundation of skeletal protection. Without it, estrogen-related bone loss can compound a nutrient deficit.
Vitamin K2 - the overlooked co-factor
Vitamin D can drive calcium absorption. Vitamin K2 (specifically MK-7) can direct that calcium into bone rather than arterial walls. Supplementing D without adequate K2 may increase soft-tissue calcification risk. The combination is well-studied and widely used in European bone health protocols; in the US it remains under-prescribed.
How much to take - and how to test
Most adults may require 2,000–4,000 IU daily to maintain 25(OH)D above 40 ng/mL, depending on baseline, body weight (higher adiposity can mean greater volumetric dilution), and sun exposure habits. Individuals with obesity or malabsorption conditions may need 6,000–10,000 IU under clinical supervision.
Take vitamin D3 (cholecalciferol, not D2) with a fat-containing meal - it is fat-soluble and absorption can drop significantly without dietary fat. Retest 25(OH)D after 90 days of consistent supplementation to confirm you've reached your target range.
References
- Song, Y., et al. (2013). Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care, 36(5), 1422-1428. PMID 23613602
- Ross, A. C., et al. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology & Metabolism, 96(1), 53-58. PMID 21118827
- Holick, M. F. (2009). Vitamin D status: measurement, interpretation, and clinical application. Annals of Epidemiology, 19(2), 73-78. PMID 18329892
- Holick, M. F., et al. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 96(7), 1911-1930. PMID 21646368
- Greendale, G. A., et al. (2012). Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). Journal of Bone and Mineral Research, 27(1), 111-118. PMID 21976317
